Skip to content
Monday, 16 November 2026Malta edition Enquire Malta-24 Briefing @CDNewsDispatch
Malta's world news feed Local perspective with global outlook
CDE.NEWS The Dispatch
Belgium

EU approves ramp-up of Pfizer vaccine manufacturing site in Belgium

epa08939349 (FILE) - Exterior view of the Pfizer production site in Puurs near Antwerp, Belgium, 22 December 2020. Pfizer Puurs is one of the largest production units in the world (reissued 15 January 2021). Pfizer on 15 January 2021 informed the European Union, which in turn informed the member states, that its Covid-19 vaccine deliveries may be delayed due to construction works at production site in Puurs. The construction works are aimed at increasing the vaccine production capacity as of mid-February 2021. All countries, with exception of USA, are delivered the vaccine from the Puurs plant. EPA-EFE/OLIVIER HOSLET

Europe’s drug regulator on Friday approved an expansion in manufacturing capacity of the Pfizer/BioNtech COVID-19 vaccine in Belgium, while recommending an approval for a new filling line at Moderna’s  site in Spain.

The European Medicines Agency (EMA) said it has approved an increase in batch size and associated process scale up at Pfizer’s vaccine manufacturing site in Puurs, Belgium.

The approval is expected to have a “significant impact on the supply of Comirnaty, the COVID-19 vaccine developed by BioNTech and Pfizer, in the European Union,” the agency said.

The move comes amid a slow vaccinations campaign in Europe, hit by problems ranging from poor coordination between national and regional authorities to a damaging contractual row with AstraZeneca.

Moderna’s new line recommended for approval will enable an increase in finished product fill activities, to adjust with the active substance scale-up process at the active substance manufacturing site approved last month, it said.

Photo: Exterior view of the Pfizer production site in Puurs near Antwerp, Belgium. EPA-EFE/OLIVIER HOSLET

Topics BelgiumPfizer

More from Belgium

More →